top of page
Why Oral Fluid?
Oral fluid provides a “blood-equivalent” result as it measures molecules similar to those found in blood plasma and its concentration correlates much closer than urine.
Oral fluid collection is less invasive, easy and quick and happens in front of you. Since bathrooms are not needed, there is no need to turn off running water, put blue dye in toilets, or perform temperature checks on specimens as is the case with urine testing.
Oral fluid testing, in general, is very cost-effective when compared to other drug testing methods.
3rd Party collection costs can be eliminated entirely.
Watch our instructional video on how to use the mLife Verify device.
Visual Interpretation of mLife Verify Results
Negative:
• Two lines appear. One line visible in the control region (C), and another line visible in the test region (T).
• This indicates the drug concentration is below the detectable level.
Positive:
• One line appears in the control region (C). No line appears in the test region (T).
• The lack of a line in the test region (T) indicates a presumptive positive result for the corresponding drug of that specific test region.
Invalid:
• Control line fails to appear.
• Insufficient specimen volume or incorrect procedural techniques are the most likely reason for control line failure.
-2.png)
-2.png)
Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs
Efforts to control SARS-CoV-2, the novel coronavirus causing COVID-19 pandemic, dependon accurate and rapid diagnostic testing. These tests must be ( 1 ) sensitive to mild andasymptomatic infections to promote effective self isolation and reduce transmission withinhigh risk groups 1; ( 2 ) consistent to reliably monitor disease progression and aid clinicaldecisions 2; and ( 3 ) scalable to inform local and national public health policies, such as when
social distancing measures can be safely relaxed.
Consistent Detection of 2019 Novel
Coronavirus in Saliva
The 2019 novel coronavirus (2019-nCoV) was detected in the
self-collected saliva of 91.7% (11/12) of patients. Serial saliva
viral load monitoring generally showed a declining trend. Live
virus was detected in saliva by viral culture. Saliva is a promising
noninvasive specimen for diagnosis, monitoring, and infection
control in patients with 2019-nCoV infection.
bottom of page